FOMAT Medical Research Earns 2024 Excellence in Patient Centricity Award
October 9, 2024 — The Society for Clinical Research Sites (SCRS) is pleased to announce that FOMAT Medical Research has been named the recipient of the 2024 Excellence in Patient Centricity Award. Sponsored by Sanofi, this award celebrates a clinical research site that consistently prioritizes patient experience in its operations.
FOMAT Medical Research distinguished itself through its innovative approach to patient recruitment and engagement, utilizing advanced artificial intelligence (AI) technologies. Their AI-driven tools, including an immediate engagement platform and the virtual assistant “Lucy,” have transformed how they interact with study participants. Lucy ensures that no call goes unanswered, giving participants a sense of being heard and valued from their first contact. Additionally, FOMAT’s use of AI-powered voiceovers in social media ads simplifies complex clinical trial information, making it more accessible and appealing to diverse patient populations.
Nicholas Focil, CEO of FOMAT, commented, “We are honored to be recognized by SCRS and even more so for their Excellence in Patient Centricity Award. This award and what it stands for, is the highest honor for us here at FOMAT It’s a reflection of our team’s unwavering dedication of always having the patients front and center. At FOMAT, we believe that innovation and technology are key to addressing the evolving needs of our patients and providing them with the best possible care throughout their research journey.”
“The Excellence in Patient Centricity Award celebrates those sites that put patients first, and FOMAT Medical Research’s innovative approach to patient-centricity is truly exceptional,” said Jimmy Bechtel, SCRS Vice President of Site Engagement. “Their use of AI to bridge the gap between patients and research sites sets a new standard in the industry. SCRS applauds their commitment to improving the clinical trial experience and ensuring that patients are engaged, respected, and prioritized at every step.”
Vicky DiBiaso, Head of Patient Informed Development & Health Value Translation, added, “Sanofi is proud to sponsor the 4th annual SCRS Excellence in Patient Centricity Award. We are deeply appreciative of the contributions all trial sites make to the advancement of medical treatments. Through this award, we are honored to celebrate FOMAT and their digital innovations making clinical research an accessible and positive experience for both patient and caregiver communities!”
2024 Excellence in Patient Centricity Award finalists included EMS Healthcare, FOMAT Medical Research, IMA Clinical Research, and Velocity Clinical Research. For more information about the Excellence in Patient Centricity Award, visit the Global Site Solutions Summit website.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
